Electrotransfer at MR imaging: Tool for optimization of gene transfer protocols - Feasibility study in mice

Radiology

Volumn 228, Issue 3, 2003, Pages 768-775

  Paturneau Jouas, Marion ^a   Parzy, Elodie ^a   Vidal, Giovanni ^a   Carlier, Pierre G ^a   Wary, Claire ^a   Vilquin, Jean Thomas ^a   De Kerviler, Eric ^b   Schwartz, Ketty ^a   Leroy Willig, Anne ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Animals; Genes and genetics; Magnetic resonance (MR), experimental studies; Therapeutic radiology, experimental studies

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROPORATION; ELECTROTRANSFORMATION; FEASIBILITY STUDY; GASTROCNEMIUS MUSCLE; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REPORTER GENE; SKELETAL MUSCLE;

ANIMALS; CONTRAST MEDIA; ELECTROPORATION; FEASIBILITY STUDIES; GADOLINIUM DTPA; GENE TRANSFER TECHNIQUES; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PLASMIDS; TRANSFECTION;

EID: 0041429156     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2283020482     Document Type: Article

References (45)

1. Yang X, Atalar E, Li D, et al. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 2001; 104:1588-1590.
2. Nichol C, Kim EE. Molecular imaging and gene therapy. J Nucl Med 2001; 42:1368-1374.
3. Bremer C, Weissleder R. In vivo imaging of gene expression. Acad Radiol 2001; 8:15-23.
4. MacLaren DC, Toyokuni T, Cherry SR, et al. PET imaging of transgene expression. Biol Psychiatry 2000; 48:337-348.
5. Honigman A, Zeira E, Ohana P, et al. Imaging transgene expression in live animals. Mol Ther 2001; 4:239-249.
6. Allamand V, Campbell KP. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet 2000; 9:2459-2467.
7. de Marco G, Bogdanov A, Marecos E, Moore A, Simonova M, Weissleder R. MR imaging of gene delivery to the central nervous system with an artificial vector. Radiology 1998; 208:65-71.
8. Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18:321-325.
9. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6:351-355.
10. Paturneau-Jouas M, Parzy E, Vidal G, et al. Electroporation-mediated delivery of a magnetic resonance imaging contrast agent into muscle to visualize electrotransfer. Acta Myol 2001; 20:174-178.
11. Neumann E, Kakorin S, Toensing K. Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 1999; 48:3-16.
12. Heller R, Jaroszeski M, Atkin A, et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389:225-228.
13. Muramatsu T, Shibata O, Ryoki S, Ohmori Y, Okumura J. Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem Biophys Res Commun 1997; 233:45-49.
14. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16: 168-171.
15. Bettan M, Ivanov MA, Mir LM, Boissiere F, Delaere P, Scherman D. Efficient DNA electrotransfer into tumors. Bioelectrochemistry 2000; 52:83-90.
16. Goto T, Nishi T, Tamura T, et al. Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A 2000; 97:354-359.
17. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16:867-870.
18. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6:508-514.
19. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 1999; 96:4262-4267.
20. Vilquin JT, Kennel PF, Paturneau-Jouas M, et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther 2001; 8:1097-1107.
21. Rizzuto G, Cappelletti M, Mennuni C, et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000; 11:1891-1900.
22. Payen E, Bettan M, Rouyer-Fessard P, Beuzard Y, Scherman D. Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA. Exp Hematol 2001; 29:295-300.
23. Pradat PF, Finiels F, Kennel P, et al. Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. Hum Gene Ther 2001; 12:367-375.
24. Chen Z, Kadowaki S, Hagiwara Y, et al. Protection against influenza B virus infection by immunization with DNA vaccines. Vaccine 2001; 19:1446-1455.
25. Vicat JM, Boisseau S, Jourdes P, et al. Muscle transfection by electroporation with high-voltage and short- pulse currents provides high-level and long-lasting gene expression. Hum Gene Ther 2000; 11: 909-916.
26. Bettan M, Emmanuel F, Darteil R, et al. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther 2000; 2:204-210.
27. Engstrom PE, Persson BR, Salford LG. Studies of in vivo electropermeabilization by gamma camera measurements of (99m)Tc-DTPA. Biochim Biophys Acta 1999; 1473:321-328.
28. Rols MP, Teissie J. Electropermeabilization of mammalian cells to macromolecules: control by pulse duration. Biophys J 1998; 75:1415-1423.
29. Soubrier F, Cameron B, Manse B, et al. pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther 1999; 6:1482-1488.
30. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22:282-287; discussion 300-303.
31. Rozijn TH, van der Sanden BP, Heerschap A, Creyghton JH, Bovee WM. Determination of in vivo rat muscle Gd-DTPA relaxivity at 6.3 T. MAGMA 1999; 9:65-71.
32. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echoplanar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999; 211:698-708.
33. Wishnia A, Alameddine H, Tardif de Gery S, Leroy-Willig A. Use of magnetic resonance imaging for noninvasive characterization and follow-up of an experimental injury to normal mouse muscles. Neuromuscul Disord 2001; 11:50-55.
34. Ferret E, Evrard C, Foucal A, Gervais P. Volume changes of isolated human K562 leukemia cells induced by electric field pulses. Biotechnol Bioeng 2000; 67:520-528.
35. Fleckenstein JL, Canby RC, Parkey RW, Peshock RM. Acute effects of exercise on MR imaging of skeletal muscle in normal volunteers. AJR Am J Roentgenol 1988; 151:231-237.
36. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998; 74:2152-2158.
37. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523:73-83.
38. Kasokat T, Urich K. Quantification of dechelation of gadopentetate dimeglumine in rats. Arzneimittelforschung 1992; 42:869-876.
39. Rudin M, Beckmann N, Porszasz R, Reese T, Bochelen D, Sauter A. In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed 1999; 12:69-97.
40. Dunn JF, Zaim-Wadghiri Y. Quantitative magnetic resonance imaging of the MDX mouse model of Duchenne muscular dystrophy. Muscle Nerve 1999; 22:1367-1371.
41. Straub V, Donahue KM, Allamand V, Davisson RL, Kim YR, Campbell KP. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med 2000; 44:655-659.
42. Unger EC, Hersh E, Vannan M, McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography 2001; 18: 355-361.
43. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6:863-867.
44. Rols MP, Bachaud JM, Giraud P, Chevreau C, Roche H, Teissie J. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res 2000; 10:468-474.
45. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res 2001; 32:273-276.